Evidence map›Paper›PMID 15798195›Full record

ArticleMolecular and cellular biology2005

Identification of neuronal enhancers of the proopiomelanocortin gene by transgenic mouse analysis and phylogenetic footprinting.

Flávio S J de Souza, Andrea M Santangelo, Viviana Bumaschny, María Elena Avale, James L Smart, Malcolm J Low, Marcelo Rubinstein

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Frontiers in neural circuits · 2025
    Article
  5. Article
  6. Article
  7. A mammalian tripartite enhancer cluster controls hypothalamicProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Enhancer redundancy in development and disease.Nature reviews. Genetics · 2021
    Review
  10. Article
  11. Comparative Transcriptomic Analyses of Developing Melanocortin Neurons Reveal New Regulators for the Anorexigenic Neuron Identity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. The Homeodomain Transcription Factor NKX2.1 Is Essential for the Early Specification of Melanocortin Neuron Identity and ActivatesThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Flávio S J de SouzaINGEBI-CONICET, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina.
Andrea M Santangelo
Viviana Bumaschny
María Elena Avale
James L Smart
Malcolm J Low
Marcelo Rubinstein
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversity of Buenos Aires · AROregon Health & Science University · USVollum Institute · US

Funding

Proopiomelanocortin Gene Expression and ObesityR01DK068400 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOW, MALCOLM JAMES · 2004 to 2022
$6.6M
NEURAL SPECIFIC REGULATION OF PROOPIOMELANOCORTIN GENE ER03TW001233 · FIC · OREGON HEALTH AND SCIENCE UNIVERSITY · PI LOW, MALCOLM JAMES · 2000 to 2005
$239k
FIC NIH HHS R03 TW001233FIC NIH HHS TW01233NIDDK NIH HHS DK68400NIDDK NIH HHS R01 DK068400
6 · The paper itself

Abstract

The proopiomelanocortin (POMC) gene is expressed in the pituitary and arcuate neurons of the hypothalamus. POMC arcuate neurons play a central role in the control of energy homeostasis, and rare loss-of-function mutations in POMC cause obesity. Moreover, POMC is the prime candidate gene within a highly significant quantitative trait locus on chromosome 2 associated with obesity traits in several human populations. Here, we identify two phylogenetically conserved neuronal POMC enhancers designated nPE1 (600 bp) and nPE2 (150 bp) located approximately 10 to 12 kb upstream of mammalian POMC transcriptional units. We show that mouse or human genomic regions containing these enhancers are able to direct reporter gene expression to POMC hypothalamic neurons, but not the pituitary of transgenic mice. Conversely, deletion of nPE1 and nPE2 in the context of the entire transcriptional unit of POMC abolishes transgene expression in the hypothalamus without affecting pituitary expression. Our results indicate that the nPEs are necessary and sufficient for hypothalamic POMC expression and that POMC expression in the brain and pituitary is controlled by independent sets of enhancers. Our study advances the understanding of the molecular nature of hypothalamic POMC neurons and will be useful to determine whether polymorphisms in POMC regulatory regions play a role in the predisposition to obesity.

Indexed as

Gene Expression RegulationPhylogenyAnimalsArcuate Nucleus of HypothalamusBase SequenceConserved SequenceDNA Mutational AnalysisEnhancer Elements, GeneticGenes, ReporterGreen Fluorescent ProteinsHumansMiceMice, TransgenicMolecular Sequence DataNeuronsObesityenhanced green fluorescent proteinGreen Fluorescent ProteinsPro-Opiomelanocortin

Identifiers

PMID15798195
PMCPMC1069613
OpenAlexW2156167660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.